PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 5, 2025Case Reports in Urology0 citationsOpen Access

Late‐Onset Penile Fracture After Collagenase Clostridium histolyticum Treatment for Peyronie’s Disease in a 70‐Year‐Old Patient

View Full Paper
MWMatthew D. WainsteinSMSonia MasihTSTimothy G. Schuster

Key Points

  • Late-onset penile fracture occurred 32 days after collagenase treatment for Peyronie’s disease.
  • Fractures generally happen within weeks of treatment; this case highlights risks may extend beyond the advised 4-week abstinence.
  • This report is only the third known instance of corporal rupture post-injection at this time period.
  • While risks typically decrease over time, complications such as penile fracture are still possible.

Abstract

Collagenase Clostridium histolyticum (CCH) injections are the gold standard for nonsurgical management of Peyronie’s disease. While generally well tolerated, penis fracture is a known complication. Cases typically occur during intercourse in the weeks following treatment. Because of this, patients are advised to abstain from sexual activity for 4 weeks postinjection. Here, we present a case of corporal rupture occurring 32 days after treatment. This is only the third reported case occurring 30 days after injection. While the risk of penis fracture likely decreases with time, these cases illustrate that the risk may extend beyond 4 weeks.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wainstein et al. (2025) studied this question.

synapsesocial.com/papers/68bb5f266d6d5674bcd0304bhttps://doi.org/10.1155/criu/2126627
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dorsal Penile Artery Avulsion After Collagenase Clostridium histolyticum (Xiaflex) for Peyronie’s Disease: A Case Report2024 · 1 citations
  2. 2(034) Two Thousand Two Hundred Patients Treated with Collagenase Clostridium Histolitycum Collagenase in a Single Centre2024
  3. 3Long-Term Satisfaction With Collagenase Clostridium Histolyticum for Peyronie’s Disease: Clinical Predictors and Side Effect Profile2024
  4. 4(873) Enhanced Outcomes of Collagenase Clostridium Histolyticum Following Adoption of Contemporary Protocol2026
  5. 5Reply: Comparison of Collagenase <i>Clostridium histolyticum</i> to Surgery for the Management of Peyronie's Disease: A Randomized Trial2024